In prostate cancer, androgen-activated nuclear AR functions as a classical transcription factor with relatively well-characterized transcriptional repertoire, including genes such as PSA, KLK2, FKBP5, and TMPRSS2, the alteration of which promotes prostate tumor aggressiveness20,21. This evidence concerns the gene KLK2 and prostate neoplasm.